Suppr超能文献

腹主动脉瘤大小对血管内主动脉瘤修复后内漏、二次干预和总体生存的影响。

The Effect of Abdominal Aortic Aneurysm Size on Endoleak, Secondary Intervention and Overall Survival Following Endovascular Aortic Aneurysm Repair.

机构信息

22606MercyOne Medical Center, Des Moines, IA, USA.

2947University of Missouri-Kansas City, MO, USA.

出版信息

Vasc Endovascular Surg. 2021 Jul;55(5):467-474. doi: 10.1177/15385744211000572. Epub 2021 Mar 15.

Abstract

OBJECTIVE

The purpose of this study was to identify the effect of abdominal aortic aneurysm (AAA) size on endoleak development and secondary intervention after endovascular repair (EVAR), as well as to examine the effect on overall survival and cause of mortality.

METHODS

Retrospective analysis was performed on all non-ruptured AAA treated by elective EVAR using FDA-approved endografts in our facility from July 2004 to December 2017. Patients were grouped into 3 cohorts based on preoperative aneurysm size: Group I (<5.5 cm), Group II (5.5-6.4 cm), and Group III (≥ 6.5 cm). Occurrences of endoleak, secondary intervention and overall survival underwent univariate and multivariate analysis. Cause of death data on deceased patients was similarly examined.

RESULTS

A total of 517 patients were analyzed. There was no difference between size groups in the rate of endoleak (Group I 48/277, 17.3%; Group II 33/160, 20.6%; Group III 18/80, 22.5%; p = 0.46) or time until endoleak development. Univariate analysis showed no difference in the rate of secondary intervention (Group I 36/277, 13.0%; Group II 24/160, 15.0%; Group III 18/80, 22.5%; p = 0.11), time until intervention or number of interventions performed. Multivariate analysis showed an association with shorter time to secondary intervention for both Group III aneurysms (HR 2.03, 95% CI 1.11-3.73; p = 0.02) and female patients (HR 1.79, 95% CI 1.02-3.13; p = 0.04). There was no difference in overall survival, aneurysm-related mortality or overall cause of mortality.

CONCLUSION

AAA diameter prior to EVAR was not associated with any differences in rates of endoleak or secondary intervention, and was not associated with poorer overall survival or greater aneurysm-related mortality. Patients with suitable anatomy for EVAR can be considered for this intervention without concern for increased complications or poorer outcomes related to large aneurysm diameter alone.

摘要

目的

本研究旨在确定腹主动脉瘤(AAA)大小对血管内修复(EVAR)后内漏发展和二次干预的影响,并探讨其对总生存率和死亡率的影响。

方法

对 2004 年 7 月至 2017 年 12 月在我院使用经美国食品和药物管理局批准的腔内移植物治疗的所有非破裂性 AAA 患者进行回顾性分析。根据术前动脉瘤大小将患者分为 3 组:I 组(<5.5cm)、II 组(5.5-6.4cm)和 III 组(≥6.5cm)。对内漏、二次干预和总生存率进行单因素和多因素分析。对死亡患者的死因数据也进行了类似的检查。

结果

共分析了 517 例患者。各组内漏发生率(I 组 48/277,17.3%;II 组 33/160,20.6%;III 组 18/80,22.5%;p=0.46)或内漏发展时间无差异。单因素分析显示,二次干预率(I 组 36/277,13.0%;II 组 24/160,15.0%;III 组 18/80,22.5%;p=0.11)、干预时间或干预次数均无差异。多因素分析显示,III 组和女性患者的二次干预时间较短(HR 2.03,95%CI 1.11-3.73;p=0.02)。总生存率、AAA 相关死亡率或总死亡率无差异。

结论

EVAR 前 AAA 直径与内漏或二次干预发生率无差异,与总生存率降低或 AAA 相关死亡率增加无关。对于适合 EVAR 的解剖结构,可考虑进行该干预,而不必担心单纯大 AAA 直径会增加并发症或不良预后。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验